Unresectable Cancer

Drug	Drug Name	Drug Description
DB06643	Denosumab	A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures.

Drug	Drug Name	Target	Type
DB06643	Denosumab	Tumor necrosis factor ligand superfamily member 11	target

Drug	Drug Name	Phase	Status	Count
DB00642	Pemetrexed	Not Available	Terminated	1
DB04485	Thymidine	Not Available	Terminated	1